Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 57
Filter
1.
Asian Pac J Allergy Immunol ; 2001 Mar; 19(1): 17-22
Article in English | IMSEAR | ID: sea-36710

ABSTRACT

The HIV-1 prime boost phase I/II vaccine trial using a recombinant canarypox vector, vCP1521, containing subtype E env (gp120), and subtype B env (gp41), gag and protease has started in Thailand. We have demonstrated that although 4 from 15 human immunodeficiency virus type 1 (HIV-1) seronegative Individuals showed cytotoxic T lymphocyte (CTL) responses to vaccinia virus antigens, none of them showed specific CTL responses to subtype E Env after in vitro stimulation. This preliminary study suggests that specific CTL responses to subtype E envelope detected in HIV-1 seronegative Individuals after vaccination should be considered as specific responses to the immunization.


Subject(s)
Adult , Antigens, Viral/immunology , B-Lymphocytes/immunology , Female , HIV Antigens/immunology , HIV Envelope Protein gp120/immunology , HIV Seronegativity/immunology , HIV-1/immunology , Herpesvirus 4, Human/immunology , Humans , Immunophenotyping , Male , Middle Aged , Reference Values , Sensitivity and Specificity , T-Lymphocytes, Cytotoxic/immunology , Thailand , Vaccinia virus/immunology
2.
Article in English | IMSEAR | ID: sea-39997

ABSTRACT

A 35-year old female patient underwent a double valve replacement. The operative findings revealed a small aortic annulus (about 17 mm in diameter). In order to implant the adequate-size prosthetic valve, the aortic and mitral annulus were enlarged using the technique described by Rastan and Manouguian. The annulus were enlarged with a patch of gel-sealed dacron graft. After the enlargement, the prosthetic valve No. 23A and 31M could be implanted in the aortic and mitral annulus, respectively. This is an effective technique to enlarge the aortic and mitral annulus in a double valve replacement procedure. The annular diameter could be increased approximately 30 per cent.


Subject(s)
Adult , Aortic Valve/surgery , Female , Heart Valve Prosthesis Implantation/methods , Humans , Mitral Valve/surgery
3.
Article in English | IMSEAR | ID: sea-43490

ABSTRACT

A 17-year-old-man who presented with syncope, had a left ventricular (LV) myxoma causing left ventricular outflow tract obstruction. The tumor was removed through left ventriculotomy using conventional cardiopulmonary bypass with good result. There have been 47 cases of LV myxoma reported in the world literature since 1957. Most of them are symptomatic (92.7%). Systemic embolism is the most common manifestation (50%) and often leads to death. The surgical removal should be performed urgently. Resection of the mass with limited normal tissue surrounding its pedicle is recommended. There are only three recurrences and five operative deaths.


Subject(s)
Adolescent , Heart Neoplasms/complications , Heart Ventricles/pathology , Humans , Male , Myxoma/complications , Treatment Outcome , Ventricular Outflow Obstruction/etiology
4.
Southeast Asian J Trop Med Public Health ; 1994 Dec; 25(4): 657-63
Article in English | IMSEAR | ID: sea-30983

ABSTRACT

The incidence of infections by Mycoplasma pneumoniae, Chlamydia trachomatis and respiratory viruses was investigated in 76 pneumonic patients aged under 6 months who attended Ramathibodi and Siriraj Hospitals in Bangkok during two study periods. M. pneumoniae infection was not found in any case from either hospital by serological diagnosis. By the isolation method, C. trachomatis infection was found in 7(16.7%) of 42 patients from Ramathibodi Hospital and 5(21.7%) of 23 patients from Siriraj Hospital with the average male:female ratio of 2.6:1; and 91.7% of the infected cases were under 3 months old. Laboratory diagnosis of respiratory virus infection was performed by indirect immunofluorescence (IIF), isolation, and by antibody detection. Data from Ramathibodi Hospital showed that 11 (24.4%), 4 (8.9%), 3 (6.7%) of the 45 patients were infected by respiratory syncytial virus (RSV), adenoviruses, parainfluenza virus type 3, and some other viruses, respectively; infection rates of 10 (32.3%), 4 (12.9%), 1 (3.2%) and 1 (3.2%) by those viruses respectively, were observed in the 31 patients from Siriraj Hospital.


Subject(s)
Chlamydia Infections/diagnosis , Chlamydia trachomatis , Cross-Sectional Studies , Developing Countries , Female , Humans , Incidence , Infant , Infant, Newborn , Male , Pneumonia, Bacterial/diagnosis , Pneumonia, Mycoplasma/diagnosis , Pneumonia, Viral/diagnosis , Thailand/epidemiology , Urban Population/statistics & numerical data
5.
Article in English | IMSEAR | ID: sea-45315

ABSTRACT

Polymerase chain reaction (PCR), viral isolation and serological methods were used to diagnose HCMV infection in infants. Specimens of urine and clotted blood were collected from suspected cases of congenital or HCMV infection who attended the Pediatric Clinic, Siriraj Hospital. Prevalence of HCMV infection was found in 3 per cent of infants aged under 14 days and increased to 48 per cent in infants aged over 14 days. PCR was the most sensitive technique, it could detect HCMV infection in 29 per cent of the study infants, whereas, detection rate by isolation was 17 per cent and by specific IgM ELISA was 15 per cent. Sensitivity and specificity of PCR compared with isolation and/or serology were 93 per cent and 96 per cent, respectively. Detection of HCMV in urine by PCR can be used as a sensitive and rapid test for diagnosis of HCMV infection in infants.


Subject(s)
Base Sequence , Cytomegalovirus/isolation & purification , Cytomegalovirus Infections/urine , Female , Humans , Infant , Infant, Newborn , Male , Molecular Sequence Data , Polymerase Chain Reaction , Sensitivity and Specificity
6.
Southeast Asian J Trop Med Public Health ; 1993 Sep; 24(3): 461-6
Article in English | IMSEAR | ID: sea-34274

ABSTRACT

During August 1988 to January 1990, the immunogenicity and safety of purified chick embryo cell rabies vaccine (PCEC) given by the conventional and abbreviated regimens in 82 vaccinees moderately to severely exposed to laboratory proven rabid animals were studied. The 16 vaccinees received PCEC six doses as conventional schedule on days 0, 3, 7, 14, 28 and 90, the 11 vaccinees received six doses of PCEC plus human rabies immune globulin (HRIG) on day 0. The 29 vaccinees received an abbreviated schedule of PCEC as two doses on day 0, one dose each on days 7 and 21 and the 26 cases received PCEC abbreviated schedule plus HRIG on day 0. The kinetics of the neutralizing antibodies on days 0, 7, 14, 28, 56, 180 and 365 were studied for comparative purpose. All vaccinees had high antibody levels from day 14 which last longer than a year and were safe after one year follow up. The adverse reactions of the vaccine were mild and self-limited.


Subject(s)
Adolescent , Adult , Animals , Antibodies, Viral/blood , Chick Embryo , Child , Child, Preschool , Drug Evaluation , Female , Follow-Up Studies , Humans , Immunization Schedule , Immunoglobulins/therapeutic use , Infant , Male , Middle Aged , Prognosis , Rabies/blood , Rabies Vaccines/therapeutic use , Rabies virus/immunology , Severity of Illness Index
7.
Southeast Asian J Trop Med Public Health ; 1993 Jun; 24(2): 260-4
Article in English | IMSEAR | ID: sea-30673

ABSTRACT

Human herpesvirus 6 (HHV-6) is a human herpesvirus isolated from patients with various lymphoproliferative disorders and acquired immunodeficiency syndrome (AIDS). The prevalence of HHV-6 infection and its correlation as a cofactor in pathogenicity of HIV infection was investigated in serum samples from 365 healthy volunteers at various age groups, 50 persons at risk for HIV-1 infection, and 90 HIV-1 seropositive individuals. Sera were screened and titrated for antibodies against HHV-6 by a standard indirect immunofluorescence assay on an acetone fixed HHV-6 infected HSB2 cells. The data show high prevalence of HHV-6 in Thailand (71.7%) and the infection is acquired early in life. Prevalence of anti-HHV-6 IgG antibodies was not strikingly different among people at risk for HIV infection, asymptomatic HIV-1 infected cases, and aged-matched controls with low risk for HIV-1 infection. The AIDS cases showed high titers of anti-HHV-6 IgG antibody and high rates for presence of anti-HHV-6 IgM antibody (33.3%) which suggests higher prevalence of HHV-6 infection by either reactivation of an earlier HHV-6 infection or a new primary infection.


Subject(s)
Acquired Immunodeficiency Syndrome/epidemiology , Adolescent , Adult , Child , Child, Preschool , Female , Fluoroimmunoassay , HIV-1/immunology , Herpesvirus 6, Human/isolation & purification , Humans , Immunoglobulin G/isolation & purification , Immunoglobulin M/isolation & purification , Infant , Male , Seroepidemiologic Studies
8.
Article in English | IMSEAR | ID: sea-43670

ABSTRACT

There is increasing evidence of vertical transmission of HIV-1 to infants through breast feeding of milk from HIV-1 infected mothers. It has been postulated that transmission occurs mainly via ingestion of infected cells in breast milk and colostrum. In this study, detection of HIV-1 proviral DNA was used to prove that cells from colostrum and milk do contain HIV. DNA were extracted from these cells of colostrum and milk of 18 seropositive mothers and amplified by nested PCR for HIV-1 gag and pol and 44 per cent were positive mostly by two primers. All ten negative control samples from seronegative mothers were negative. This study demonstrated the infectivity of breast milk and colostrum. Nevertheless, recommendation against breast-feeding should be weighed against poor alternatives in low socioeconomic families.


Subject(s)
Adult , Colostrum/microbiology , DNA, Viral/analysis , Female , HIV Seropositivity/microbiology , HIV-1/isolation & purification , Humans , Milk, Human/microbiology , Polymerase Chain Reaction
9.
Southeast Asian J Trop Med Public Health ; 1991 Sep; 22(3): 326-31
Article in English | IMSEAR | ID: sea-33143

ABSTRACT

The present study reports on the prevalence of specific IgA and IgG antibodies to EBV viral capsid antigen in nasopharyngeal carcinoma (NPC) patients with different histological types of carcinoma and their age-matched controls by the indirect immunofluorescence test, using the B-95-8 lymphoblastoid cell line as source of viral capsid antigen. EBV specific IgG was found in almost all the study cases, and antibody titers were significantly higher in the NPC patients than in non-cancer controls. GMT of anti-EBV IgG in NPC patients, patients with other malignant diseases, and those with non-malignant diseases were 371.5, 97.7 and 35.5, respectively. Anti-EBV specific IgA was more specific to NPC than was IgG, and was present in 86.5% (83 of 96) cases of NPC patients, 6.6% (2 of 30) of patients with other cancers, and 3.1% (3 of 97) cases of non-malignant diseases. A weak correlation between level of anti-EBV IgA in NPC patients was observed (r = 0.3). EBV IgA was found in all histological types of NPC, ie, WHO types 1, 2 and 3, but WHO type 1 was rare among NPC patients in Thailand. Use of anti-EBV IgA for monitoring cancer therapy is to be further investigated.


Subject(s)
Adolescent , Adult , Age Factors , Aged , Aged, 80 and over , Antigens, Viral/immunology , Biomarkers/blood , Capsid , Capsid Proteins , Carcinoma/blood , Carcinoma, Squamous Cell/blood , Female , Fluorescent Antibody Technique , Humans , Immunoglobulin A/blood , Immunoglobulin G/blood , Male , Middle Aged , Nasopharyngeal Neoplasms/blood , Seroepidemiologic Studies , Sex Factors , Thailand/epidemiology
12.
Asian Pac J Allergy Immunol ; 1989 Jun; 7(1): 41-6
Article in English | IMSEAR | ID: sea-36814

ABSTRACT

Thailand is an endemic area for rabies, with approximately 300 human deaths reported annually. More than half of the rabies patients are children under 14 years of age. This paper reports clinical data of paediatric rabies cases occurring from 1980 to 1986, and the protective efficacies of human diploid cell rabies vaccine (HDCV) and purified Vero cell rabies vaccine (PVRV) in children exposed to rabid animals. The analysis of 120 medical records revealed that rabies in children had incubation periods which ranged from less than fifteen days to more than three months, but generally between one to three months. The most frequent symptoms observed in the patients were hydrophobia, restlessness, fever, vomiting and aerophobia. Most of the rabid children admitted to hospital died within 24 hours. HDCV was administered to 50 children exposed to rabies with the cumulative dosages of 327 ml. All patients survived without serious adverse effects during a-two year follow-up. Mild reactions were seen in 1.5 percent (5/327 doses). Unfortunately, levels of rabies antibody in these vaccinees were not determined. Among another series of children exposed to rabid animals, comprising 27 individuals who received a total of 168 doses of PVRV, only mild local reactions were seen in 6 subjects. No rabies deaths were reported in 2 years of follow-up. The children who received PVRV either with or without human rabies immune globulin developed similar levels of rabies neutralizing (NT) antibody, which reached the high titers on day 30. At one year after the first dose of vaccination, all vaccinees still had NT antibody at titers higher than 0.5 IU/ml.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Adolescent , Age Factors , Animals , Antibodies, Viral/immunology , Child , Child, Preschool , Dogs , Female , Humans , Infant , Injections, Subcutaneous , Male , Rabies/drug therapy , Rabies Vaccines/administration & dosage , Rabies virus/immunology , Sex Factors , Thailand , Time Factors
13.
Asian Pac J Allergy Immunol ; 1988 Jun; 6(1): 1-2
Article in English | IMSEAR | ID: sea-37083
14.
Southeast Asian J Trop Med Public Health ; 1988 Jun; 19(2): 191-5
Article in English | IMSEAR | ID: sea-32651

ABSTRACT

The prevalence of antibodies to delta virus (anti-delta) in the selected groups of hepatitis B surface antigenemia population was investigated. The subjects were 84 intravenous drug abusers; 20 chronic hepatitis, 12 cirrhosis, 6 primary hepatocellular carcinoma and 46 asymptomatic healthy carriers. Anti-delta was detected in 65.48% of intravenous drug abusers, 11.11% of chronic active hepatitis and 8.33% of cirrhosis cases. None of asymptomatic carriers had anti-delta. In addition, 51 acute icteric hepatitis B patients who were positive for HBs Ag and 20 IV drug abusers positive for anti-HBc only (HBsAg and anti-HBs negative) were negative for anti-delta.


Subject(s)
Adult , Female , Hepatitis Antibodies/analysis , Hepatitis B/immunology , Hepatitis B Surface Antigens/analysis , Hepatitis D/complications , Hepatitis Delta Virus/immunology , Humans , Injections, Intravenous , Liver Diseases/immunology , Liver Neoplasms/immunology , Male , Middle Aged , Substance-Related Disorders/complications , Thailand
20.
Asian Pac J Allergy Immunol ; 1985 Dec; 3(2): 179-82
Article in English | IMSEAR | ID: sea-36749

ABSTRACT

Antibodies to cytomegalovirus (CMV) were determined in Thai blood donors using the complement fixation (CF) test and enzyme-linked immunosorbent assay (ELISA). A total of 203 voluntary blood donors, 181 males and 22 females, who came to the Blood Bank at Siriraj Hospital during February 1985, were investigated. Their ages ranged from 17 to 53 years (mean 24.3 +/- 6.9). Seventy-three out of 156 (46.8%) and 171 out of 203 (84.2%) sera were positive for CMV antibodies as detected by the CF test and ELISA respectively. The result of ELISA showed that 95.5 per cent of the female blood donors and 82.9 per cent of the males possessed CMV antibodies. No difference in the geometric mean titres of either sex was noted. The findings indicated that ELISA was more sensitive than the CF test for detecting CMV antibodies. The high percentage of CMV-seropositive blood donors indicates that CMV infection is common in this country. Therefore, it might be necessary to test blood donors for CMV antibodies when they are giving blood for use by certain patients, especially immunocompromised ones; the same observation applies with regard to organ donors before transplantation is carried out.


Subject(s)
Adolescent , Adult , Antibodies, Viral/analysis , Blood Donors , Blood Transfusion/adverse effects , Complement Fixation Tests , Cytomegalovirus/immunology , Cytomegalovirus Infections/etiology , Enzyme-Linked Immunosorbent Assay , Female , Humans , Male , Middle Aged , Thailand , Tissue Donors
SELECTION OF CITATIONS
SEARCH DETAIL